CMS Seeks to Improve Enrollee Experience in 2026 Medicare Advantage and Part D Final Rule but Declines to Include Several Key Proposals
This Bulletin is brought to you by AHLA’s Payers, Plans, and Managed Care Practice Group.
- May 30, 2025
- Melissa Wong , Holland & Knight LLP
The Centers for Medicare & Medicaid Services (CMS) codified in its 2026 Medicare Advantage (MA) and Part D Final Rule (2026 Final Rule) several provisions from the Inflation Reduction Act of 2022 (IRA) in advance of the launch of Maximum Fair Prices under the Medicare Drug Price Negotiation Program, as fully described in Part 1 of this Medicare Advantage and Part D Final Rule Bulletin. In this Part 2 summary, we focus on other changes included in the 2026 Final Rule as well as which proposals CMS declined to finalize this time around.
ARTICLE TAGS
You must be logged in to access this content.